Calamos Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.1M Buy
62,131
+14,191
+30% +$2.32M 0.03% 410
2026
Q2
$7.19M Sell
47,940
-2,728
-5% -$297K 0.02% 491
2026
Q1
$4.68M Sell
50,668
-5,800
-10% -$582K 0.02% 570
2025
Q4
$5.77M Buy
56,468
+11,968
+27% +$1.07M 0.02% 505
2025
Q3
$2.78M Buy
+44,500
New +$2.42M 0.01% 603

Other funds holding GH

Calamos Advisors's GH Position: Q3 2026 in Review

Calamos Advisors increased its Guardant Health (GH) stake by 30% in Q3 2026, buying an estimated $2.32M and bringing the position to 62,131 shares worth $11.1M. The position accounts for 0.03% of the portfolio, ranked #410.

Calamos Advisors first reported a position in GH in Q3 2025 and has held it in 5 quarters since. 670 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Calamos Advisors held 62,131 shares of Guardant Health worth $11.1M as of Q3 2026.
  • Calamos Advisors bought 14,191 Guardant Health shares in Q3 2026, an estimated $2.32M.
  • Guardant Health made up 0.03% of Calamos Advisors's portfolio in Q3 2026, its #410 holding.
  • Calamos Advisors first reported a position in Guardant Health in Q3 2025 and has held it in 5 quarters since.
  • 670 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Calamos Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.